Legal Representation
Attorney
Bradley P. Hartman
USPTO Deadlines
Application History
38 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 15, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Aug 15, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jan 13, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 12, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jan 12, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jan 5, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jan 5, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 6, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 2, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jul 2, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 2, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 24, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 22, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Dec 22, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Dec 22, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 1, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 1, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 1, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 18, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 16, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Dec 16, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Dec 16, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 9, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 14, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 14, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 24, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 1, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 13, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 13, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 11, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
Mar 8, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 10, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 10, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 10, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 4, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 20, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 18, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
Class 005
Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
Class 042
Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
Class 044
Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions
Additional Information
Translation
The English translation of "PROFERO" in the mark is "DELAY".
Classification
International Classes
001
005
042
044